Mesothelioma Risk Among Navy Veterans is Focus of New Report
A new study offers a sobering reminder of the mesothelioma risk among Navy veterans. Researchers at Vanderbilt University compared mesothelioma…
-
-
Immunotherapy for Peritoneal Mesothelioma: New Drug Trial Begin
Researchers in Maryland and Missouri have started human testing of a new type of immunotherapy for peritoneal mesothelioma. If the… -
Asbestos | Asia | Diagnosis | International | New Techniques | Prognosis
Japanese Discovery Could Lead to New Mesothelioma Blood Test
A discovery in Japan could lead to a more effective mesothelioma blood test for mesothelioma diagnosis. Japanese scientists say they… -
Biomarkers | Diagnosis | Genetics | New Drugs | Research | Treatments
Genetics-Based Cancer Treatment Could Mean New Hope for Mesothelioma
The FDA has approved a new genetics-based cancer treatment that could open the door for more targeted mesothelioma therapy. The… -
Radiation May Help Mesothelioma Immunotherapy Treatment Work Better
Hypofractionated radiation for mesothelioma could change how doctors treat this rare cancer. Researchers in Toronto, Canada have been testing hypofractionated… -
Acupuncture for Cancer May Relieve Mesothelioma Symptoms
There is new evidence that acupuncture may help relieve some of the worst symptoms of cancer and cancer treatment. The… -
Alternatives | Chemotherapy | Europe | International | New Drugs | New Studies | Research | Treatments
Study Suggests Sugar Supplement Could Slow Growth of Mesothelioma
A sugar supplement might be able to slow the growth of mesothelioma and others types of cancer. The sugar supplement… -
Mesothelioma Surgery PD Comparison
Lung-sparing surgery is another name for pleurectomy/decortication (PD). In PD, surgeons take out as much mesothelioma cancer as they can… -
Belgian Mesothelioma Survival Study
A new Belgian mesothelioma survival study contains important insights for patients and doctors. Cancer center researchers did the study with… -
Alternatives | Asia | International | New Drugs | Treatments
When Chemotherapy Fails: Apatinib May Offer Third-Line Option for Mesothelioma Patients
An investigational drug being developed in China may offer a third lifeline to mesothelioma patients whose cancer does not respond…
